Abiopharma

Clinical trial NCT07318324 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-06-03 → 2026-05-13

EMPLOYERS Appoints Jeffrey P. Lisenby as Executive Vice President, General Counsel

Jackson Named InvestmentNews 2026 Annuities Provider of the Year

Emergent BioSolutions Secures Contract Modification Valued at Approximately $52.7 Million for ACAM2000® (Smallpox and Mpox (Vaccinia) Vaccine, Live) from the U.S. Government

Enveric Biosciences Announces Participation in B. Riley Securities Mind, Muscle & Vision Summit

Scrip Election/ Distribution/ DRP:

Calix to Post Second Quarter 2026 Results on July 20, 2026

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer: Change in interest of Director - Ow Chio Kiat

InTest Joins Russell 2000 and Rusell 3000 Indexes

Tenable Achieves FedRAMP High and Impact Level 5 Authorization